Tizanidine Tablet
Product Images NDC 67877-613

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 67877-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz-01 (Tiz 01)

Chemical structure of tizanidine hydrochloride, showing the molecular arrangement with a chlorinated benzene ring fused to a thiazole and an imidazoline ring system.*

FDA Label Image

Tiz-02 (Tiz 02)

A pharmacokinetic line graph showing plasma tizanidine concentration (ng/mL) over 24 hours from dosing. It compares 2 x 4 mg tizanidine tablets and capsules taken with and without food, illustrating differences in absorption profiles based on dosage form and food intake.*

FDA Label Image

Tiz-03 (Tiz 03)

A line graph depicting improvement in Ashworth Score over time after dosing, comparing 16 mg and 8 mg base tizanidine doses against placebo. The x-axis shows hours post-dose from 0 to 6, and the y-axis displays the improvement score with data points and error bars indicating variability.*

FDA Label Image

Tiz-04 (Tiz 04)

A line graph comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis shows study weeks labeled End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis represents improvement score ranging from -6 to 2, with tizanidine showing greater improvement across all time points compared to placebo.*

FDA Label Image

Tiz-2mg-150s (Tiz 2mg 150s)

Label for Tizanidine Tablets, USP 2 mg, an oral tablet medication. The label indicates a package size of 150 tablets, Rx only, manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. It includes a warning that Tizanidine Tablets are not interchangeable with Tizanidine Capsules. The label also provides storage instructions and an NDC 67877-613-15 with barcodes.*

FDA Label Image

Tiz-4mg-150s (Tiz 4mg 150s)

Label for Tizanidine Tablets, USP 4 mg oral tablets, in a package containing 150 tablets. The label states the active ingredient strength as 4 mg, includes storage and dispensing instructions, and indicates the product is Rx only. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. The label includes a warning that Tizanidine Tablets are not interchangeable with capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.